# Market Signal Brief, manual test run, 2026-09-08

| Field | Value |
|---|---|
| Why it ran | Venkat asked to run every scheduled task once to confirm they work |
| Session | https://claude.ai/code/session_01W8dt66hGnhBBcMrrSbUqxd |
| Status | finished, success, 52 turns, 672 seconds (about 11 minutes), claude-opus-5. Full brief produced, about 40,000 characters. |
| Drive save | failed: the cloud session's Drive connector exposes only share, trash, and rename |
| Web reading | blocked for every page it tried (sec.gov, veeva.com, ir.veeva.com, investing.com, fiercepharma.com, mmm-online.com and others). It built the brief from search snippets and labeled every number as 'reported, not verified at the source'. |
| Delivered | attached the brief as a text file in the session, and sent one mobile push |

## Result, as visible in the run log (the full brief is in the session)

What matters today, in the brief's words: three things. Large pharma is re-deciding where its
customer record lives and adding AI agents on top of it in the same motion (Veeva reported its
best customer relationship management quarter, with Eli Lilly and Biogen selecting Vault CRM,
twelve of the top twenty biopharma companies now; Salesforce has Novartis on a five-year global
rollout). The United States Food and Drug Administration is now running AI against drug
advertising at scale. And a policy push on drug pricing and advertising, plus an agency using
automation to cover reduced staff.

Evidence caution from the run: every number rests on search result summaries.

## What this run proved

- The full analysis loop works and follows the twelve-heading structure. It is long: the
  prompt says concise, and eleven minutes of research produced a very long brief. Worth
  watching over the first week and tightening if it stays that long.
- Quality is capped by the network block. See the README section "Known blockers".
